Trial of Decitabine in Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the results in older patients who have newly
diagnosed or secondary acute myeloid leukemia (AML) and who are to either receive decitabine
or patient's choice with the physician's advice of either cytarabine or supportive care
medication.